Human immunodeficiency virus infection and the skin

A crucial interface

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The skin is commonly affected in the course of human immunodeficiency virus (HIV) infection. In many cases, skin findings may be the earliest sign of HIV disease or acquired immunodeficiency syndrome. When cutaneous diseases occur in unusual settings, such as zoster in a young individual, are increased in severity or fail to respond to routine therapy, the possibility of underlying immunodeficiency should be suspected. Skin diseases in HIV-infected hosts include primary infections, such as those caused by herpes simplex virus and molluscum contaglosum, as well as secondary involvement of systemic diseases, such as cryptococcosis and histoplasmosis. Noninfectious inflammatory processes, such as seborrheic dermatitis and psoriasis, as well as neoplasms, such as Kaposi's sarcoma and basal cell carcinoma, may all be seen in these patients. We review a number of these diseases and discuss their treatment. Clinicians must be aware of the cutaneous manifestations of HIV infection so that the disease will be recognized at an earlier point in time and therapy with zidovudine and prophylactic antibiotics will be instituted where appropriate.

Original languageEnglish (US)
Pages (from-to)1295-1303
Number of pages9
JournalArchives of Internal Medicine
Volume151
Issue number7
StatePublished - 1991

Fingerprint

Virus Diseases
HIV
Skin
Skin Diseases
Seborrheic Dermatitis
Skin Manifestations
Cryptococcosis
Histoplasmosis
Zidovudine
Mollusca
Kaposi's Sarcoma
Basal Cell Carcinoma
Herpes Zoster
Simplexvirus
Psoriasis
Acquired Immunodeficiency Syndrome
Therapeutics
Anti-Bacterial Agents
Infection
Neoplasms

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Human immunodeficiency virus infection and the skin : A crucial interface. / Cockerell, Clay J.

In: Archives of Internal Medicine, Vol. 151, No. 7, 1991, p. 1295-1303.

Research output: Contribution to journalArticle

@article{3b5792e6fdfd4494a55b17e36b2bfec3,
title = "Human immunodeficiency virus infection and the skin: A crucial interface",
abstract = "The skin is commonly affected in the course of human immunodeficiency virus (HIV) infection. In many cases, skin findings may be the earliest sign of HIV disease or acquired immunodeficiency syndrome. When cutaneous diseases occur in unusual settings, such as zoster in a young individual, are increased in severity or fail to respond to routine therapy, the possibility of underlying immunodeficiency should be suspected. Skin diseases in HIV-infected hosts include primary infections, such as those caused by herpes simplex virus and molluscum contaglosum, as well as secondary involvement of systemic diseases, such as cryptococcosis and histoplasmosis. Noninfectious inflammatory processes, such as seborrheic dermatitis and psoriasis, as well as neoplasms, such as Kaposi's sarcoma and basal cell carcinoma, may all be seen in these patients. We review a number of these diseases and discuss their treatment. Clinicians must be aware of the cutaneous manifestations of HIV infection so that the disease will be recognized at an earlier point in time and therapy with zidovudine and prophylactic antibiotics will be instituted where appropriate.",
author = "Cockerell, {Clay J.}",
year = "1991",
language = "English (US)",
volume = "151",
pages = "1295--1303",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Human immunodeficiency virus infection and the skin

T2 - A crucial interface

AU - Cockerell, Clay J.

PY - 1991

Y1 - 1991

N2 - The skin is commonly affected in the course of human immunodeficiency virus (HIV) infection. In many cases, skin findings may be the earliest sign of HIV disease or acquired immunodeficiency syndrome. When cutaneous diseases occur in unusual settings, such as zoster in a young individual, are increased in severity or fail to respond to routine therapy, the possibility of underlying immunodeficiency should be suspected. Skin diseases in HIV-infected hosts include primary infections, such as those caused by herpes simplex virus and molluscum contaglosum, as well as secondary involvement of systemic diseases, such as cryptococcosis and histoplasmosis. Noninfectious inflammatory processes, such as seborrheic dermatitis and psoriasis, as well as neoplasms, such as Kaposi's sarcoma and basal cell carcinoma, may all be seen in these patients. We review a number of these diseases and discuss their treatment. Clinicians must be aware of the cutaneous manifestations of HIV infection so that the disease will be recognized at an earlier point in time and therapy with zidovudine and prophylactic antibiotics will be instituted where appropriate.

AB - The skin is commonly affected in the course of human immunodeficiency virus (HIV) infection. In many cases, skin findings may be the earliest sign of HIV disease or acquired immunodeficiency syndrome. When cutaneous diseases occur in unusual settings, such as zoster in a young individual, are increased in severity or fail to respond to routine therapy, the possibility of underlying immunodeficiency should be suspected. Skin diseases in HIV-infected hosts include primary infections, such as those caused by herpes simplex virus and molluscum contaglosum, as well as secondary involvement of systemic diseases, such as cryptococcosis and histoplasmosis. Noninfectious inflammatory processes, such as seborrheic dermatitis and psoriasis, as well as neoplasms, such as Kaposi's sarcoma and basal cell carcinoma, may all be seen in these patients. We review a number of these diseases and discuss their treatment. Clinicians must be aware of the cutaneous manifestations of HIV infection so that the disease will be recognized at an earlier point in time and therapy with zidovudine and prophylactic antibiotics will be instituted where appropriate.

UR - http://www.scopus.com/inward/record.url?scp=0025882711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025882711&partnerID=8YFLogxK

M3 - Article

VL - 151

SP - 1295

EP - 1303

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 7

ER -